Eidos Therapeutics, Inc.

United States of America

 
Total IP 15
Total IP Rank # 100,624
IP Activity Score 1.9/5.0    12
IP Activity Rank # 73,072
Stock Symbol EIDX (nasdaq)
ISIN US28249H1041
Market Cap. 2,900M  (USD)
Industry Biotechnology
Sector Healthcare

Patents

Trademarks

8 0
3 0
4 0
0
 
Last Patent 2024 - Potent transthyretin (ttr) stabi...
First Patent 2018 - Processes for preparing 3-(3-(3,...

Latest Inventions, Goods, Services

2024 Invention Potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis. Descri...
Invention Processes for preparing ag-10, its intermediates, and salts thereof. Provided herein are improve...
2022 Invention Formulations of ag10. The present disclosure provides high-load tablet formulations of AG10 or a ...
2021 Invention Processes for preparing ag-10, its intermediates, and salts thereof. Provided herein are improved...
Invention Methods of treating ttr amyloidosis using ag10. Described herein are methods for treating transth...
2018 Invention Processes for preparing 3-(3-(3,5-dimethyl-1h-propoxy)-4-fluorobenzoic acid, its intermediates, a...
Invention Process for preparing ag-10, its intermediates, and salts thereof. Provided herein are improved p...